Total Payments
$1,046
2024 Payments
$287.87
Companies
15
Transactions
62
Medicare Patients
1,016
Medicare Billing
$102,434
Payment Breakdown by Category
Food & Beverage$1,046 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,046 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $210.87 | 12 | $0 (2024) |
| Novo Nordisk Inc | $193.21 | 12 | $0 (2024) |
| ABBVIE INC. | $146.66 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $122.96 | 8 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $110.28 | 7 | $0 (2024) |
| Organon LLC | $38.64 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $37.61 | 2 | $0 (2024) |
| Exact Sciences Corporation | $36.43 | 2 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $30.92 | 2 | $0 (2019) |
| Amgen Inc. | $25.74 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $287.87 | 16 | Lilly USA, LLC ($95.09) |
| 2023 | $290.02 | 17 | Lilly USA, LLC ($100.11) |
| 2022 | $189.93 | 12 | Novo Nordisk Inc ($64.38) |
| 2021 | $150.35 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($58.43) |
| 2020 | $96.53 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($64.53) |
| 2019 | $30.92 | 2 | JAZZ PHARMACEUTICALS INC. ($30.92) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Gastroenterology | ||||||
| 04/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Obesity | ||||||
| 01/29/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROLOGY | ||||||
| 03/19/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 239 | 579 | $64,944 | $25,531 |
| 2022 | 7 | 289 | 585 | $57,265 | $27,411 |
| 2021 | 7 | 248 | 520 | $54,907 | $24,918 |
| 2020 | 8 | 240 | 533 | $59,118 | $24,574 |
Total Patients
1,016
Total Services
2,217
Medicare Billing
$102,434
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 243 | $38,795 | $18,726 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 80 | $8,788 | $4,193 | 47.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 86 | 198 | $3,366 | $1,663 | 49.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,895 | $474.97 | 16.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 46 | $11,100 | $473.88 | 4.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 252 | $39,595 | $19,579 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 94 | $10,295 | $5,135 | 49.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 22 | 22 | $990.00 | $970.20 | 98.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,743 | $866.47 | 31.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 89 | 174 | $2,958 | $515.16 | 17.4% |
| 90471 | Administration of vaccine | Office | 2022 | 14 | 15 | $312.75 | $192.00 | 61.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 15 | $372.15 | $153.78 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 275 | $43,904 | $22,234 | 50.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 23 | $2,526 | $1,350 | 53.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 76 | 145 | $2,465 | $435.00 | 17.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 26 | $780.00 | $428.22 | 54.9% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 21 | 22 | $458.70 | $224.06 | 48.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 18 | $4,500 | $154.56 | 3.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 11 | 11 | $272.91 | $91.76 | 33.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 297 | $42,779 | $20,890 | 48.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $4,124 | $1,719 | 41.7% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 19 | 20 | $900.00 | $899.10 | 99.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 66 | 111 | $1,887 | $328.26 | 17.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 18 | 35 | $7,833 | $307.40 | 3.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 19 | $750.00 | $306.90 | 40.9% |
About Dr. Wilfred Miller, DO
Dr. Wilfred Miller, DO is a Family Medicine healthcare provider based in Midlothian, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073599205.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wilfred Miller, DO has received a total of $1,046 in payments from pharmaceutical and medical device companies, with $287.87 received in 2024. These payments were reported across 62 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,046).
As a Medicare-enrolled provider, Miller has provided services to 1,016 Medicare beneficiaries, totaling 2,217 services with total Medicare billing of $102,434. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Midlothian, TX
- Active Since 12/20/2005
- Last Updated 03/01/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073599205
Products in Payments
- Ozempic (Drug) $116.10
- XIFAXAN (Drug) $110.28
- VYVANSE (Drug) $107.79
- VRAYLAR (Drug) $101.94
- JARDIANCE (Drug) $86.16
- MOUNJARO (Drug) $76.44
- UBRELVY (Drug) $61.00
- EMGALITY (Drug) $50.36
- Rybelsus (Drug) $45.32
- NEXPLANON (Drug) $38.64
- TRELEGY ELLIPTA (Drug) $37.61
- Cologuard Collection Kit (Device) $36.43
- XYREM (Drug) $30.92
- Otezla (Drug) $25.74
- Kyleena (Drug) $22.18
- ZEPBOUND (Drug) $19.48
- Xofluza (Drug) $19.04
- RYBELSUS (Drug) $16.07
- Saxenda (Drug) $15.72
- TRINTELLIX (Drug) $15.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midlothian
Donald Sanders, M.d, M.D
Family Medicine — Payments: $18,297
Family Medicine $18,297
Joseph Goddard, M.d, M.D
Family Medicine — Payments: $17,178
Family Medicine $17,178
Dr. Joseph Castro, D.o, D.O
Family Medicine — Payments: $14,548
Family Medicine $14,548
William Morrissette, M.d, M.D
Family Medicine — Payments: $13,896
Family Medicine $13,896
Dr. Laura Aisenberg, M.d, M.D
Family Medicine — Payments: $13,402
Family Medicine $13,402
Damian Covington, M. D, M. D
Family Medicine — Payments: $12,759
Family Medicine $12,759